Association of single nucleotide polymorphisms of cytochrome P450 enzymes with experience of vasomotor, vaginal and musculoskeletal symptoms among breast cancer patients: a systematic review

Association of single nucleotide polymorphisms of cytochrome P450 enzymes with experience of vasomotor, vaginal and musculoskeletal symptoms among breast cancer patients: a systematic review

Abstract Background Adjuvant endocrine therapies are known to induce undesirable adverse effects such as vasomotor, vaginal and musculoskeletal symptoms among breast cancer patients. Drugs used in these therapies are often metabolised by cytochrome P450 (CYP) enzymes, in which their metabolising act...

Full description

Bibliographic Details
Main Authors: Carmen W. H. Chan, Bernard M. H. Law, Marques S. N. Ng, Corinna C. Y. Wong, Carissa W. Y. Wong, Morgan Quinley, Jessica M. Orgusyan, Ka Ming Chow, Mary M. Y. Waye
Format: Article
Language:English
Published: BMC 2021-05-01
Series:BMC Cancer
Subjects:
Breast cancer patients
Adjuvant endocrine therapy
Cytochrome P450
Single nucleotide polymorphisms
Genotype
Symptom
Online Access:https://doi.org/10.1186/s12885-021-08268-8

Internet

https://doi.org/10.1186/s12885-021-08268-8

Similar Items